生命科学资讯

Drugmakers frustrated by vaccine schedule overhaul

Jazz and Zymeworks spell out HER2 bispecific win

FDA report claiming Covid vaccine link to children's deaths misses deadline

Why Agilent (A) Stock Is Up Today - TradingView — Track All Markets

3 biopharma CEOs explain why they are 'authentically optimistic' for 2026

J&J plans late-stage trial for lupus candidate after Phase 2 success

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Appeals court says no to cap on indirect costs in NIH grants

Drugs to Watch 2026: 11 therapies that could transform patient care

New year sees Abbvie, Zelgen in $1.1B T-cell engager deal

AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil

Insilico inks $888M drug discovery partnership with Servier

Scinopharm wins US FDA approval of multiple sclerosis drug

Alumis soars as TYK2 drug hits mark in psoriasis trials

Bright Minds' shares soar on positive Phase 2 seizure reduction data

Alumis' TYK2 drug succeeds in key psoriasis studies, will seek FDA approval

Amgen buys protein-degrading startup Dark Blue for up to $840M

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - PharmiWeb.com

A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration

Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors